Discover nova’s MiDD approach

Nova’s modeling and simulation approach combines mathematical models of diseases and treatments with virtual patients into an integrated clinical trial simulation platform called jinkō. Nova builds disease and treatment computational models based on knowledge extracted from literature and data. To simulate a trial, we run those models on virtual patients with appropriate simulated scenarios (in silico experimental protocols) to predict the clinical efficacy of new drugs at the population level before in-human trials take place

Are you planning for your upcoming MiDD (Model-informed Drug Development) programs? Do you want to learn more about the methodology behind in silico clinical trials? Download our white paper.


  1. How do in silico clinical trials work?
  2. How do we build models?
  3. What are the applications?

white paper

Get your questions answered by downloading the free pdf and learn more about our study!

  • Your information will be processed by Nova to send you the content requested. For more information about our processing or to exercise your GDPR rights, see our Privacy Policy
  • This field is for validation purposes and should be left unchanged.